F373-0530 Screening compound: 4-{4-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]phenyl}morpholine

F373-0530 Screening compound: 4-{4-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]phenyl}morpholine
F373-0530 Screening compound: 4-{4-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]phenyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound F373-0530
4-{4-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]phenyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F373-0530

Molecular Formula

C21H21N3O2 (C21 H21 N3 O2)

Compound Name

4-{4-[5-(1-phenylcyclopropyl)-1,2,4-oxadiazol-3-yl]phenyl}morpholine

IUPAC name

4-{4-[5-(1-phenylcyclopropyl)-124-oxadiazol-3-yl]phenyl}morpholine

SMILES

C(C1)C1(c1nc(-c(cc2)ccc2N2CCOCC2)no1)c1ccccc1

InChI

InChI=1S/C21H21N3O2/c1-2-4-17(5-3-1)21(10-11-21)20-22-19(23-26-20)16-6-8-18(9-7-16)24-12-14-25-15-13-24/h1-9H,10-15H2

InChI Key

XQDSVYQSSVZPHJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27120746

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

347.42

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.049

Distribution Coefficient, logD

4.049

Water Solubility, LogSw

-4.27

Polar Surface Area

43.257

Acid Dissociation Constant (pKa)

22.14

Base Dissociation Constant (pKb)

4.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

F373-0530 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Akt-Targeted Library (14764 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with F373-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F373-0530?
Check Price and Availability of F373-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F373-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F373-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F373-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F373-0530 available by request